| 5-HT4 | 5-hydroxytryptamine/serotonin 4 |
| CNS | Central nervous system |
| DMV | Dorsal motor nucleus of the vagus |
| ENS | Enteric nervous system |
| FMT | Fecal microbiota transplant |
| FDA | Food and Drug Administration |
| GI | Gastrointestinal |
| GLP-2 | Glucagon-like peptide-2 |
| IBD | Inflammatory bowel disease |
| IBS | Inflammatory bowel syndrome |
| ITT | Intestinal transit time |
| LB | Lewy bodies |
| MPTP | 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine |
| NMES | Neuromuscular electrical stimulation |
| PD | Parkinson’s disease |
| PEG | Polyethylene glycol |
| SNpc | Substantia nigra pars compacta |
| TJ | Tight junction |
| VIP | Vasoactive intestinal peptide |